Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis

Kim Papp*, Kenneth Gordon, Diamant Tha├ži, Akimichi Morita, Melinda Gooderham, Peter Foley, Ihab G. Girgis, Sudeep Kundu, Subhashis Banerjee

*Corresponding author for this work
66 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase 2 trial of selective tyrosine kinase 2 inhibition in psoriasis'. Together they form a unique fingerprint.

Medicine & Life Sciences